1[1]Exner DV,Dries DL,Domanski MJ,et al.Lesser response to angiotensin-converting-enzyme inhibitor therapy in black as compared with white patients with left ventricular dysfunction[J].N Engl J Med,2001,344:1351.
2[2]Rathore SS,Wang Y,Krumholz HM.Sex-based differences in the effect of digoxin for the treatment of heart failure[J].Med,2002,347:1403.
3[3]Shibata M,Flather M,Bohm M,et al.Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS)[J].Int J Cardiol,2002,86:77.
4[4]Poirier P,Bogaty P,Garneau C,et al.Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes:importance of manoeuvres in echocardiographic screening for preclinical diabetic cardiomyopathy[J].Diabetes Care,2001,24:5.
5[5]Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction[J].N Engl J Med,2002,346:877.
6[6]Remme WJ,Swedberg K.Guidelines for the diagnosis and treatment of chronic heart failure[J].Eur Heart J,2001,22:1527.
7[7]Moss AJ,Zareba W,Hall WJ,et al.Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction[J].N Engl J Med,2002,346:877.
8[8]Krum H,Ninio D,MacDonald P.Baseline predictors of tolerability to carvedilol in patients with chronic heart failure[J].Heart,2000,84:615.
9[9]Krum H,McMurray JJV.Statins and chronic heart failure:do we need a large-scale outcome trial[J].Am Coll Cardiol,2002,39:1567.
10[10]Bauersachs J,Galuppo P,Fraccarollo D,et al.Improvement of left ventricular remodeling and function by hydroxymethylglutaryl coenzyme a reductase inhibition with cerivastatin in rats with heart failure after myocardial infarction[J].Circulation,2001,104:982.
7Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and man- agement of chronic heart failure in the adult [ J]. Circulation, 2005, 112(12): e154-235.
8Greenberg B. Treatment of heart failure: state of the art and prospective[J ]. J Cardiovasc Pharma- col, 2001, 38(Suppl 2): S59-S63.
9Dries DL, Sweitzer NK, Drazner MH, et al. Prog- nostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ven- tricular systolic dysfunction[ J ]. J Am Coil Cardiol, 2001, 38 (2) : 421 -428.
